According to FDA statement, Becton Dickinson (BDX) is “recalling one lot of ChloraPrep Clear 1 mL applicators due to fungal contamination under ...
Barclays raised the firm’s price target on Becton Dickinson (BDX) to $279 from $278 and keeps an Overweight rating on the shares. The firm says ...
The global butterfly needle sets market is witnessing significant expansion, driven by increasing chronic disease prevalence, advancements in medical technology, and growing demand for minimally ...
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...